A single dose of the AstraZeneca vaccine may reduce transmission of coronavirus by two thirds, according to a new study.
Researchers said that the first dose of the AstraZeneca/Oxford jab offers protection of 76 per cent up to three months and may reduce transmission by 67 per cent – with efficacy rising to 82.4 per cent after the second dose 12 weeks later.
The data from the study by the University of Oxford, which has not yet been peer reviewed, supports the four to 12-week prime-boost dosing interval that many global regulators have recommended.
Before these results, little was known about how effective the Covid-19 vaccines were at preventing transmission of the disease.
The findings indicate that those who have been vaccinated are not only protected from the disease, but that they are not likely to pass on the virus to anyone.
It also suggests the vaccine eliminates severe illness, as none of those in the study were admitted to hospital with coronavirus.
Professor Andrew Pollard, chief investigator of the Oxford Vaccine Trial and study co-author, said: “These new data provide an important verification of the interim data that was used by more than 25 regulators including the MHRA (Medicines and Healthcare products Regulatory Agency) and EMA (European Medicines Agency) to grant the vaccine emergency use authorisation.
“It also supports the policy recommendation made by the [UK's] Joint Committee on Vaccination and Immunisation (JCVI) for a 12-week prime-boost interval, as they look for the optimal approach to roll out, and reassures us that people are protected from 22 days after a single dose of the vaccine.”
A former chair at the Faculty of Pharmaceutical Medicine, Dr Gillies O’Bryan-Tear, said the results were the first definitive estimate of the impact of vaccination on transmission rates.
“If the effect on transmission is confirmed for the Pfizer vaccine too, this would be very positive,” he said.
